過敏免疫療法的全球市場:市場規模，佔有率，成長分析，各治療類型(皮下免疫療法，舌下免疫療法)，各過敏類型，各流通管道-產業預測(2022年～2028年)

Global Allergy Immunotherapy Market Size, Share, Growth Analysis, By Treatment Type(Subcutaneous Immunotherapy, Sublingual Immunotherapy ), By Allergy Type, By Distribution Channel - Industry Forecast 2022-2028

出版日期: 2022年11月06日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球過敏免疫療法的市場規模，從2021年的25億美元，預計2028年成為62億美元，從2022年到2028年的預測期間內的年複合成長率成為9.2％。工業化和人口的擴大，醫療和醫療的進步，新的免疫治療藥的引進，促進市場成長。

本報告提供全球過敏免疫療法市場的相關調查，市場概要，市場分析，企業簡介等全面性資訊。

市場動態
促進因素
機會
阻礙因素
課題
法規情形
SWOT分析
波特五力分析
競爭企業間的敵對關係
替代品的威脅
買方議價能力
新加入業者的威脅
供給企業談判力
未來的混亂相關Skyquest的特別的洞察
政治影響
經濟影響
社會影響
技術性影響
環境的影響
法律上的影響

全球過敏免疫療法市場:各治療類型

市場區隔
皮下免疫療法
舌下免疫療法
口腔過敏免疫療法

全球過敏免疫療法市場:各過敏類型

市場區隔
過敏性鼻炎
氣喘
食物過敏
藥物過敏

全球過敏免疫療法市場:各流通管道

市場區隔
醫院藥局
零售藥局
藥妝店
線上藥局

市場規模:各地區

北美
美國
加拿大
歐洲
德國
西班牙
法國
英國
其他的歐洲
亞太地區
中國
印度
日本
韓國
其他的亞太地區
南美
巴西
其他的南美
中東、非洲
GCC各國
南非
其他的中東、非洲

主要企業簡介

競爭情形
成為對象的企業的總數
主要企業的市場定位
主要企業的市場佔有率
ALK Abello(英國)
Allergy Therapeutics(英國)
Circassia(英國)
DBV Technologies(英國)
HAL Allergy Group(英國)
Merck KGaA Allergopharma(英國)
Stallergenes Greer(英國)
Allergopharma(德國)
Aimmune Therapeutics(美國)
Leti Pharma(西班牙)
Jubilant HollisterStier(美國)

簡介目錄

Product Code: SQSG35I2019

Global allergy immunotherapy market was valued to be USD 2.5 billion in 2021, and it is anticipated to reach USD 6.2 billion by 2028 at a CAGR of 9.2% over the forecast period (2022-2028).

According to the World Allergy Organization, 10-30% of the global population is currently affected by various types of allergies. Allergy occurs when the immune system of the body becomes abnormally sensitive to certain substances, such as a specific meal, pollen, fur, or dust. Food, dust, pollen, latex, medicines, and other allergens are examples of allergies. During allergy immunotherapy, the body is exposed to little levels of allergens in order to produce antibodies against them. Immunotherapy involves low-dose exposure to certain allergens on a frequent basis to help the body acclimatise to their presence, resulting in effective and rapid allergy treatment.

The expansion of industrialization and population, advancements in healthcare and medicine, and the introduction of new immunotherapeutic drugs are the key factors driving the global market for allergy immunotherapy. Recent regulatory approvals, such as those for oral dissolvable tablets, are being expanded in order to raise the worldwide allergy immunotherapy market share.

Top-down and bottom-up approaches were used to estimate and validate the size of global allergy immunotherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Segments covered in this report:

The Global Allergy Immunotherapy Market is segmented based on treatment type, allergy type, distribution channel and region. Based on the Treatment Type, it is categorized into Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), and Oral Allergy Immunotherapy. Based on Allergy Type, it is categorized into Allergic Rhinitis, Asthma, Food Allergy, and Drug Allergy. Based on the Distribution Channel, it is categorized into Hospital Pharmacies, Retail Pharmacies and Drug Stores, and Online Pharmacies. Based on region, it is categorized into North America, Europe, Asia Pacific, The Middle East and Africa, and Latin America.

Drivers

Increasing allergy cases to help the allergy immunotherapy market grow: The increased prevalence of various allergies, as well as the development of novel sublingual immunotherapies in emerging countries, are the primary drivers of allergy immunotherapy market expansion. According to the American College of Allergy, Asthma, and Immunology, allergies are the sixth most frequent chronic ailment in the United States, costing more than USD 18 billion each year and affecting more than 50 million individuals. Food allergies are growing more widespread in both children and adults all around the world. As a result, the increased burden of allergic diseases is expected to boost demand for novel immunotherapies.

Restraints

Allergy immunotherapy, the most recent technology on the market, necessitates monthly maintenance. The cost of normal maintenance is relatively high due to the specific demand for professional workers in the process. As a result of this, the system's operational costs will climb. This is the primary cause or factor that is expected to severely impede the global allergy immunotherapy market. Furthermore, there is a need to increase awareness of this microgrid management system among many organizations, since this factor's ignorance of new technological developments may prove to be a barrier to the market's expansion for these systems.

Market Trends

High-resolution study of rare cells in local tissues has enabled the development of accurate and dependable biomarkers for allergy immunotherapy monitoring.

Aside from immunoglobulin and T-cell receptor transcript repertoires, genome-wide epigenetic changes provide a source of potential biomarkers for allergy immunotherapy monitoring.

Rare, antigen-specific immune cells can be counted and immuno-phenotyped using modern multiparameter flow and mass cytometry to track allergy immunotherapy.

Executive Summary

Market overview

Exhibit: Executive Summary - Chart on Market Overview
Exhibit: Executive Summary - Data Table on Market Overview
Exhibit: Executive Summary - Chart on Global Global Allergy Immunotherapy Market Characteristics
Exhibit: Executive Summary - Chart on Market by Geography
Exhibit: Executive Summary - Chart on Market Segmentation
Exhibit: Executive Summary - Chart on Incremental Growth
Exhibit: Executive Summary - Data Table on Incremental Growth
Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

Market Dynamics
Exhibit: Impact analysis of DROC, 2021
Drivers
Opportunities
Restraints
Challenges
SWOT Analysis

KEY MARKET INSIGHTS

Technology Analysis
(Exhibit: Data Table: Name of technology and details)
Pricing Analysis
(Exhibit: Data Table: Name of technology and pricing details)
Supply Chain Analysis
(Exhibit: Detailed Supply Chain Presentation)
Value Chain Analysis
(Exhibit: Detailed Value Chain Presentation)
Ecosystem Of the Market
Exhibit: Parent Market Ecosystem Market Analysis
Exhibit: Market Characteristics of Parent Market
IP Analysis
(Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
Trade Analysis
(Exhibit: Data Table: Import and Export data details)
Startup Analysis
(Exhibit: Data Table: Emerging startups details)
Raw Material Analysis
(Exhibit: Data Table: Mapping of key raw materials)
Innovation Matrix
(Exhibit: Positioning Matrix: Mapping of new and existing technologies)
Pipeline product Analysis
(Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
Macroeconomic Indicators

COVID IMPACT

Introduction
Impact On Economy-scenario Assessment
Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
Revised Market Size
Exhibit: Data Table on Global Global Allergy Immunotherapy Market size and forecast 2021-2027 ($ million)
Impact Of COVID On Key Segments
Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
COVID Strategies By Company
Exhibit: Analysis on key strategies adopted by companies